Navigation Links
Study of Pathwork Diagnostics' Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
Date:12/14/2007

en laboratories. Overall concordance between laboratories in terms of final tissue of origin calls was 93.8%.

"As a result of the study, we concluded that the Pathwork Tissue of Origin Test is a robust assay that produces consistent results in diverse laboratory conditions reflecting the pre-analytical variations found in the everyday clinical practice of molecular diagnostics laboratories," explained Catherine I. Dumur, Ph.D., of Virginia Commonwealth University, lead author of the manuscript.

"This test has the potential to be an effective aid in the diagnosis of cancer patients presenting with poorly differentiated and undifferentiated tumors," commented Dr. Monzon, now at The Methodist Hospital in Houston, TX.

Note: The Pathwork Tissue of Origin Test is not cleared by the FDA for sale in the U.S. It is for Investigational Use Only.

About Pathwork Diagnostics

Pathwork Diagnostics, based in Sunnyvale, California, develops and delivers genomics-based diagnostics that advance cancer care. The company solves unmet clinical needs in oncology by using innovative technology to harness the power of genomics information and apply it in a robust, reproducible and reliable manner. Pathwork Diagnostics plans to deliver FDA-cleared microarray-based diagnostic tests for oncology to the clinical laboratory. The company's initial tests will consist of Pathwork Diagnostics' proprietary analytics and a companion Pathchip(TM) microarray, which runs on the proven Affymetrix instrument system. The company's first test -- the Pathwork(R) Tissue of Origin Test -- is designed to be an aid in the diagnosis of the tissue of origin in patients with poorly or undifferentiated tumors or metastases.

(1) Pavlidis, Fizazi. Cancer of unknown primary. Critical Reviews in

Oncology Hematology 54 (2005) 243-50.

(2) Tong et al. Incidence, costs of care and survival of Medicare

beneficiaries diagnosed with carcinoma of unknown
'/>"/>

SOURCE Pathwork Diagnostics
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2008)...RNewswire-FirstCall/ -- Cytopia Limited,(ASX: CYT)...g oral,presentation on CYT997 at the 2008 Annual M...y (ASCO) will be accessible to the public via ASCO...rsday 15 May (US EDT)., The oral presentation, en...toxic and vascular disrupting agent, in patients w...
(Date:5/15/2008)...ted in Blacks, Hispanics/Latinos, People ...IPPANY, N.J., May 15 /- Daiichi Sanky...e American Society of,Hypertension,s Twenty- Third...ns demonstrated that the powerful combination drug...fely and effectively helped,patients across severa...
(Date:5/15/2008)...France, May 15 /- Cerenis,Therapeutic...mpany,developing HDL-related compounds for the tre...oday announced that it has completed a Phase I,cli... product candidates.,CER-002 is a peroxisome proli...gonist in development for the treatment of cardiov...
(Date:5/15/2008)...RNewswire/ -- Tigris Pharmaceuticals,Inc. announc...nd,Development Agreement (CRADA) with the National... and preclinical development of AFP-464, an,aminof...s converted to,metabolites which bind covalently t... This is part of a four-year CRADA encompassing m...
Breaking Medicine Technology:Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3Web Hosted Attendance on Demand 28R 29 Introduces Innovative Web Time Clock 1948 1Web Hosted Attendance on Demand 28R 29 Introduces Innovative Web Time Clock 1948 2Team finds an economical way to boost the vitamin A content of maize 1947 1Team finds an economical way to boost the vitamin A content of maize 1947 2Team finds an economical way to boost the vitamin A content of maize 1947 3Former Sufferer of Rare Disease Called Musicogenic Epilepsy Thanks LIJ Medical Team That Ended Her Seizures and Gave Her Back the Gift of Music 9743 1Former Sufferer of Rare Disease Called Musicogenic Epilepsy Thanks LIJ Medical Team That Ended Her Seizures and Gave Her Back the Gift of Music 9743 2Jan Marini Skin Research Suspends Sales of Popular Eyelash Products 9740 1Jan Marini Skin Research Suspends Sales of Popular Eyelash Products 9740 2
...ivery System, dermal patch and a direct,current ..., SEATTLE, March 20, 2007 /PRNewswire/ -- Dharma...ransdermal drug delivery company,and wholly owne...,("TTI"), Tokyo, Japan announced that its active ...rs lidocaine and epinephrine,through the skin vi...
...20, 2007--Researchers studying influenza,transmiss...pical,areas, specifically Brazil, uncovered the un...s from low populated regions near the,equator to t...he,Fogarty International Center (NIH), part of the...planning for influenza control in,tropical areas. ...
Other Medicine Technology:Dharma Therapeutics Shows IDDS Is Effective in Reducing Pain,Associated With Insertion of an Intravenous Catheter in Their Phase,2 Clinical Trial 2Dharma Therapeutics Shows IDDS Is Effective in Reducing Pain,Associated With Insertion of an Intravenous Catheter in Their Phase,2 Clinical Trial 3Researchers Find Surprising Pattern of Influenza Spread in South,America and Tropics 2Researchers Find Surprising Pattern of Influenza Spread in South,America and Tropics 3
(Date:5/17/2008)... But report could not establish safe-limit price ...RDAY, May 17 (HealthDay News) -- Those inexpensive...t may be good for your wallet but bad for your ear...s of earrings sold for less than $50 by local San ... can cause dermatitis on the earlobes and repeated...
(Date:5/16/2008)... LOS ANGELES, May 16 /PRNewswire/ -- In the a...00 people are thought to have lost their lives, an...on people have been,affected, with 4 million who h...widespread losses and suffering, Supreme Master Ch...al of US$50,000. With contributions from,Supreme M...
(Date:5/16/2008)... BENSALEM, Pa., May 16 /PRNewswire/ -- Law Of... deadline to move to be a lead plaintiff in the,se...ll persons who,purchased or otherwise acquired the...c. ("Inverness Medical" or the "Company") (Amex: ...n or about November 14, 2007 (the,"Class Period")....
(Date:5/16/2008)... Poor levels also cause increase in serum parathy...IDAY, May 16 (HealthDay News) -- Low levels of vit...e parathyroid glands may increase the risk of depr... , The Dutch study, published in the May issue...vious speculation by researchers that vitamin D, d...
Breaking Medicine News(10 mins):Health News:Cheaper Earrings More Likely to Contain Nickel 2Health News:Cheaper Earrings More Likely to Contain Nickel 3Health News:Supreme Master Ching Hai International Association Delivering US$160,000 in Aid to Earthquake Survivors in China 2Health News:Law Offices of Howard G. Smith Announces 24 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Inverness Medical Innovations, Inc. 2Health News:Low Vitamin D Tied to Depression in Older Adults 2
...ted by Kenneth Norman, Sean Polyn and Jonathan Coh...avel. It was funded by the National Institute of H... to various events that has occurred in the past. ...ental state. The research is of great importance ...
... health care disparities occurs in the use of new ...s and children’s, which make them not accessible t... Researchers from Massachusetts General Hospital h...is found in minority and children’s affected with ...
..., Ph.D, student at Public University of Navarre ha... dioxide is found to have anti-cancer effects//. S...es and found 23 compounds from it had antitumor ac...ial studies have found that the benzotiophene deri...
...tmas gift for a large number of obese people who w...ition is minimum sweat to the body.// The answer c...School associate professor of medicine and foundin...ealth Centre who has come up with a novel plan. It...
Other Medicine News:Health News:Mystery behind Brain activity during recalling events disentangled 2
PeriVac Pericardiocentesis Kit with 7F pigtail catheter
Designed to minimize emblolic debris in SVGs and carotids
...y of interventional cardiologists and cardiothorac...provides non-interventional cardiologists with a m... who have become refractory to drugs. Vasomedical'...treatment for coronary artery disease, and offers ...
The dual lumen petite titanium model comes with a 1.0 mm catheter (each lumen) and is our smallest model. Dual oval lumen catheters offer larger lumen equivalency while maintaining maximum catheter s
Medicine Products: